Krsnaa Diagnostics Limited (KRSNAA) Stock Statistics & Valuation Metrics

Krsnaa Diagnostics Limited has a market cap or net worth of ₹17.10B. The enterprise value is ₹26.56K.

Krsnaa Diagnostics Limited has 32,438,670 shares outstanding. The number of shares has decreased by -2.65% in one year.

Krsnaa Diagnostics Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 5.85%.

The current PE Ratio of Krsnaa Diagnostics Limited is 16.9. Krsnaa Diagnostics Limited’s PEG ratio is 0.55.

In the last 12 months, Krsnaa Diagnostics Limited had revenue of 7.73B and earned 1.01B in profits. Earnings per share was 31.30.

In the last 12 months, operating cash flow was 518.74M and capital expenditures -1.04B, giving a free cash flow of -516.97M billion.

Krsnaa Diagnostics Limited pays an annual dividend of ₹2.75, resulting in a dividend yield of 0.52%

Krsnaa Diagnostics Limited upcoming earnings date is Nov 5, 2026, Before Open (Confirmed).

Krsnaa Diagnostics Limited as a current ratio of 2.68, with Debt / Equity ratio of 54.50%

In the past 12 months, Krsnaa Diagnostics Limited has paid 289.36M in taxes.

Krsnaa Diagnostics Limited EV to EBITDA ratio is 7.29, with an EV/FCF ratio of -19.73.

Krsnaa Diagnostics Limited has ₹3.61B in cash and marketable securities with ₹5.34B in debt, giving a net cash position of -₹1.74B billion.

Gross margin is 54.00%, with operating margin of 15.71%, and net profit margin of 13.13%.

The average price target for Krsnaa Diagnostics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―